Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis

被引:121
|
作者
Li, Bao-Zhu [1 ,2 ]
Threapleton, Diane Erin [3 ]
Wang, Ji-Yao [4 ]
Xu, Jian-Ming [5 ]
Yuan, Jin-Qiu [3 ]
Zhang, Chao [1 ,2 ]
Li, Peng [1 ,2 ]
Ye, Qian-Ling [6 ]
Guo, Biao [6 ]
Mao, Chen [3 ,7 ]
Ye, Dong-Qing [1 ,2 ]
机构
[1] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hefei, Anhui, Peoples R China
[2] Anhui Med Univ, Anhui Prov Lab Populat Hlth & Major Dis Screening, Hefei, Anhui, Peoples R China
[3] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Epidemiol, Hong Kong, Hong Kong, Peoples R China
[4] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China
[5] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Peoples R China
[6] Anhui Med Univ, Affiliated Hosp 2, Hefei, Anhui, Peoples R China
[7] Chinese Univ Hong Kong, Hong Kong Branch, Chinese Cochrane Ctr, Hong Kong, Hong Kong, Peoples R China
来源
关键词
QUADRUPLE CONCOMITANT THERAPY; TRIPLE 1ST-LINE THERAPY; SEQUENTIAL THERAPY; DUODENAL-ULCER; DRUG THERAPY; OPEN-LABEL; ERADICATION; INFECTION; MANAGEMENT; PROBIOTICS;
D O I
10.1136/bmj.h4052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine the most efficacious treatment for eradication of Helicobacter pylori with the lowest likelihood of some common adverse events among pre-recommended and newer treatment regimens. Design Systematic review and network meta-analysis. Data sources Cochrane Library, PubMed, and Embase without language or date restrictions. Study selection Full text reports of randomised controlled trials that compared different eradication treatments for H pylori among adults. Results Of the 15 565 studies identified, 143 were eligible and included. Data on 14 kinds of treatments were available. Of 91 possible comparisons for the efficacy outcome, 34 were compared directly and the following treatments performed better: seven days of concomitant treatment (proton pump inhibitor and three kinds of antibiotics administered together), 10 or 14 days of concomitant treatment, 10 or 14 days of probiotic supplemented triple treatment (standard triple treatment which is probiotic supplemented), 10 or 14 days of levofloxacin based triple treatment (proton pump inhibitor, levofloxacin, and antibiotic administered together), 14 days of hybrid treatment (proton pump inhibitor and amoxicillin used for seven days, followed by a proton pump inhibitor, amoxicillin, clarithromycin, and 5-nitroimidazole for another seven days), and 10 or 14 days of sequential treatment (five or seven days of a proton pump inhibitor plus amoxicillin, followed by five or seven additional days of a proton pump inhibitor plus clarithromycin and 5-nitroimidazole or amoxicillin). In terms of tolerance, all treatments were considered tolerable, but seven days of probiotic supplemented triple treatment and seven days of levofloxacin based triple treatment ranked best in terms of the proportion of adverse events reported. Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Helicobacter pylori Infection and Psoriasis: A Systematic Review and Meta-Analysis
    Yu, Mingyang
    Zhang, Rongguang
    Ni, Peng
    Chen, Shuaiyin
    Duan, Guangcai
    [J]. MEDICINA-LITHUANIA, 2019, 55 (10):
  • [22] The effectiveness of treatments for Kashin–Beck disease: a systematic review and network meta-analysis
    Kun Zou
    Jinliang Hu
    Qiao Zhou
    Jiang Su
    Birong Dong
    Weiya Zhang
    [J]. Clinical Rheumatology, 2019, 38 : 3595 - 3607
  • [23] Association of hypertension with helicobacter pylori: A systematic review and meta-analysis
    Fang, Yizhen
    Xie, Huabin
    Fan, Chunming
    [J]. PLOS ONE, 2022, 17 (05):
  • [24] Comparative efficacy of treatments for molluscum contagiosum: A systematic review and network meta-analysis
    Chao, Yuan-Chen
    Ko, Mei-Ju
    Tsai, Wan-Chuan
    Hsu, Le-Yin
    Wu, Hon-Yen
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 (06): : 599 - 599
  • [25] Network meta-analysis for comparative effectiveness of treatments for chronic low back pain disorders: systematic review protocol
    Belavy, Daniel L.
    Diwan, Ashish D.
    Ford, Jon
    Miller, Clint T.
    Hahne, Andrew J.
    Mundell, Niamh
    Tagliaferri, Scott
    Bowe, Steven
    Pedder, Hugo
    Saueressig, Tobias
    Zhao, Xiaohui
    Chen, Xiaolong
    Balasundaram, Arun Prasad
    Arora, Nitin Kumar
    Owen, Patrick J.
    [J]. BMJ OPEN, 2021, 11 (11):
  • [26] COMPARATIVE EFFICACY OF HELICOBACTER PYLORI ERADICATION THERAPIES: A NETWORK META-ANALYSIS
    Malfertheiner, Peter
    Moss, Steven F.
    Daniele, Patrick
    Pelletier, Corey
    Jacob, Rinu
    Tremblay, Gabriel
    Hubscher, Elizabeth M.
    Chey, William D.
    [J]. GASTROENTEROLOGY, 2022, 162 (07) : S872 - S872
  • [27] FIRST-LINE HELICOBACTER PYLORI ERADICATION REGIMENS: A SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS
    Zhao, X.
    Wu, W.
    [J]. VALUE IN HEALTH, 2016, 19 (03) : A317 - A317
  • [28] SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF TREATMENTS FOR SCHIZOPHRENIA
    Phalguni, A.
    McCool, R.
    Wood, H.
    Sanderson, A.
    Rydevik, G.
    Franklin, B.
    James, D.
    [J]. VALUE IN HEALTH, 2020, 23 : S584 - S584
  • [29] Comparative Effectiveness of Treatments for Bacterial Vaginosis: A Network Meta-Analysis
    Munoz-Barreno, Alison
    Cabezas-Mera, Fausto
    Tejera, Eduardo
    Machado, Antonio
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (08):
  • [30] Comparative Effectiveness of Therapies for Graves' Hyperthyroidism: A Systematic Review and Network Meta-Analysis
    Sundaresh, Vishnu
    Brito, Juan P.
    Wang, Zhen
    Prokop, Larry J.
    Stan, Marius N.
    Murad, Mohammad H.
    Bahn, Rebecca S.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (09): : 3671 - 3677